Trial site
Hepato-Gastroenterologie HK, s.r.o.
- 31running trials
- 20closed trials
The trials here
What the 51 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease27 trials
- Ulcerative colitis26 trials
- Primary biliary cholangitis5 trials
- Eosinophilic oesophagitis1 trial
- Phase
- Phase 327 trials
- Phase 222 trials
- Phase 2/32 trials
- Status
- Completed19 trials
- Recruiting16 trials
- Active, not recruiting12 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Lead sponsor
- AbbVie7 trials
- Janssen Research & Development, LLC5 trials
- Takeda5 trials
- Merck Sharp & Dohme LLC3 trials
- Abivax S.A.2 trials
- and 23 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Active, not recruiting
Recruiting
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Recruiting
Recruiting
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Active, not recruiting
Recruiting
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Active, not recruiting
Recruiting
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease14 recruiting
- Ulcerative colitis8 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Recruiting
Completed
A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.
Completed
Completed
Terminated
Completed
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Active, not recruiting
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Completed
Completed
VTX002 versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Completed
Completed
Completed
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026